
Valeo Pharma Investor Relations Material
Latest events

Q3 2024
Valeo Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Valeo Pharma Inc
Access all reports
Valeo Pharma Inc. is a specialty pharmaceutical company engaged in the acquisition, in-licensing brands and sale of pharmaceutical products with primary focus on respiratory, speciality and hospital generic products in Canada. The Company's core competencies include clinical research, regulatory affairs and drug safety. The Company focuses on marketing approved products through its prescription division as well as niche markets such as respiratory through specialty divisions.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
VPH
Country
🇨🇦 Canada